Innovations In Clinical Neuroscience

MAY-JUN 2017

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link: http://innovationscns.epubxp.com/i/862254

Contents of this Issue

Navigation

Page 6 of 35

[ V O L U M E 1 4 , N U M B E R 5 – 6 , M A Y – J U N E 2 0 1 7 ] Innovations in CLINICAL NEUROSCIENCE 7 Editorial Advisory Board E DITOR Amir H. Kalali, MD—Professor of Psychiatry, University of California, San Diego, California EXECUTIVE EDITOR Elizabeth A. Klumpp—Vice President, Editorial Director, Matrix Medical Communications, West Chester, Pennsylvania ADVISORY BOARD Ahmed Aboraya, MD, DrPH—Chief of Psychiatry, William R. Sharpe, Jr. Hospital; Clinical Professor of Psychiatry, West Virginia School of Osteopathic Medicine; Director of World Health Organization (WHO) SCAN Training and Reference Center, West Virginia University, Morgantown, West Virginia A. Ari Albala, MD, DFAPA—Clinical Prof. of Psychiatry, University of California, San Diego; Medical Director, Psychiatric Centers at San Diego; Clinical Director, Geriatric Psychiatry Program, Aurora Behavioral Health, San Diego, California Per Bech, MD—Professor of Psychiatry, Psychiatric Research Unit, Frederiksborg General Hospital, Hillerød, Denmark Thomas C. Benfield, MD—Clinical Assistant Professor, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania Robert M. Bilder, PhD, ABPP-CN— Michael E. Tennenbaum Family Professor of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA; Professor of Psychology, UCLA College of Letters and Science, Los Angeles, California P ierre Blier, MD, PhD—Professor of Psychiatry and Cellular and Molecular Medicine, University of Ottawa; Canada Research Chair, Psychopharmacology, Endowed Chair and Director, Mood Disorders Research Unit, Institute of Mental Health Research, Ottawa, Canada Michel S. Bourin, MD, PharmD— Psychiatrist, Professor of Pharmacology, Nantes University, Nantes, France; Adjunct Professor, Department of Psychiatry, Edmonton University, Alberta, Canada; Visiting Professor, University of Craiova, Romania Peter Buckley, MD—Dean, Medical College of Georgia, Georgia Health Sciences University, Augusta, Georgia William E. Bunney, Jr., MD—Associate Dean for Research Administration and Development, Distinguished Professor, Della Martin Chair, Psychiatry, University of California, Irvine Joseph R. Calabrese, MD—Bipolar Disorders Research Chair and Professor of Psychiatry, Director, Mood Disorders Program, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio Dennis S. Charney, MD—Dean, Mount Sinai School of Medicine; Executive Vice President for Academic Affairs, the Mount Sinai Medical Center; Anne and Joel Ehrenkranz Professor, Departments of Psychiatry, Neuroscience, and Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP—Professor and Associate Dean for Clinical Programs, University of North Texas System College of Pharmacy, Fort Worth, Texas; Emeritus Professor of Pharmacotherapy, College of Pharmacy, Washington State University–Spokane D avid L. Copolov, MB BS, PhD, DPM, MPM, FRACP, FRANZCP—Pro Vice- Chancellor, Office of the Vice Chancellor and President, Professor of Psychiatry, Monash University; Professor of Psychiatry, University of Melbourne, Victoria, Australia Vladimir Coric, Jr., MD—Associate Clinical Professor of Psychiatry, Yale OCD Research Clinic; Director, Global Clinical Research-Neuroscience, Bristol-Myers Squibb Company, Wallingford, Connecticut Michael Davidson, MD—Professor and Chairman, Department of Psychiatry, Tel Aviv University, Israel Robin Emsley, MD—Professor and Head, Department of Psychiatry, University of Stellenbosch, Cape Town, South Africa Kenneth R. Evans, PhD—Department of Psychiatry, University of Toronto; President and CEO, Ontario Cancer Biomarker Network, Toronto; Associate Professor, Dept of Pathology and Laboratory Medicine, Queen's University, Kingston, Ontario, Canada David Feifel, MD, PhD—Professor, Department of Psychiatry; Director, Neuropsychiatry and Behavioral Medicine Program; Director, UCSD Adult ADHD Program, University of California, San Diego Medical Center, San Diego, California Timothy W. Fong, MD—Assistant Clinical Professor, Director of the Impulse Control Disorders Clinic, Co-Director of the UCLA Gambling Studies Program, Director of UCLA Addiction Psychiatry Fellowship, David Geffen School of Medicine at UCLA, Semel Institute of Neuroscience and Behavior, Department of Psychiatry and Biobehavioral Sciences, Los Angeles, California Continued on page 9

Articles in this issue

Archives of this issue

view archives of Innovations In Clinical Neuroscience - MAY-JUN 2017